Gerald B. Pier

Founder en Alopexx Enterprises LLC .

72 años

Consumer Services

Health Technology

Perfil

Gerald B.
Pier was the founder of Alopexx, Inc. (founded in 2019) and served as the Chief Scientific Advisor.
Dr. Pier is also the founder of Alopexx Enterprises LLC.
Currently, Dr. Pier is a Professor at Harvard Medical School.
In terms of education, Dr. Pier holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of the Pacific.

Cargos activos de Gerald B. Pier

Empresas	Cargo	Inicio
Harvard Medical School	Corporate Officer/Principal	-
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA.	Founder	-

Todos los cargos activos de Gerald B. Pier

Antiguos cargos conocidos de Gerald B. Pier.

Empresas	Cargo	Fin
ALOPEXX, INC.	Founder	-

Ver el detalle de la experiencia de Gerald B. Pier.

Formación de Gerald B. Pier.

University of California, Berkeley	Doctorate Degree
University of the Pacific	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gerald B. Pier.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Alopexx Enterprises LLC Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA.	Health Technology
Alopexx, Inc. Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA.	Health Technology